Efficiency of Nitrous Acid as An Inactivating and Mutagenic Agent of Intact Tobacco Mosaic Virus and Its Isolated Nucleic Acid 1
AUTOR(ES)
Sehgal, O. P.
RESUMO
When tobacco mosaic virus (TMV) and its isolated nucleic acid (TMV-RNA) were treated with nitrous acid, the nucleic acid was inactivated six times faster than the intact virus. Inactivation of both the infectious entities was exponential with treatment time to 0.1% level of survival. Eight different mutant phenotypes were scored after inactivation of TMV and TMV-RNA to 50, 10, 1.0, and 0.1% survival levels. Significantly more mutants in relation to unaltered isolates were induced at all levels of survival upon nitrous acid treatment of TMV than of TMV-RNA. Furthermore, the proportion of two specific mutant phenotypes was significantly greater in treated TMV than in treated TMV-RNA. No qualitative differences, however, were observed between the mutational spectra of nitrous acid-treated TMV and TMV-RNA. These results indicate that, in the intact virus, the viral capsid protects some of the sites involved in lethality; thus, proportionately more mutants are induced on nitrous acid treatment of TMV versus TMV-RNA.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=375425Documentos Relacionados
- RECONSTITUTION OF ACTIVE TOBACCO MOSAIC VIRUS FROM ITS INACTIVE PROTEIN AND NUCLEIC ACID COMPONENTS*
- OBSERVATIONS ON THE BIOLOGICAL BEHAVIOR OF TOBACCO MOSAIC VIRUS NUCLEIC ACID
- THE ARRANGEMENT OF PURINE AND PYRIMIDINE NUCLEOTIDES IN TOBACCO MOSAIC VIRUS NUCLEIC ACID*
- Cell-free synthesis of tobacco mosaic virus coat protein and its combination with ribonucleic acid to yield tobacco mosaic virus.
- ON THE DISTRIBUTION OF PURINE AND PYRIMIDINE BASES IN THE NUCLEIC ACID OF TOBACCO MOSAIC VIRUS
